vs
Esperion Therapeutics, Inc.（ESPR）与Sprout Social, Inc.（SPT）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是Sprout Social, Inc.的1.4倍（$168.4M vs $120.9M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs 12.9%），过去两年Sprout Social, Inc.的营收复合增速更高（11.8% vs 10.6%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Sprout Social, Inc.是一家提供社交媒体管理平台服务的科技企业，由贾斯汀·霍华德等四位创始人在2010年成立，总部位于美国芝加哥，目前是一家上市企业。其推出的平台能够帮助企业统一管理多渠道社媒账号，开展营销互动与数据分析工作。
ESPR vs SPT — 直观对比
营收规模更大
ESPR
是对方的1.4倍
$120.9M
营收增速更快
ESPR
高出130.8%
12.9%
两年增速更快
SPT
近两年复合增速
10.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $120.9M |
| 净利润 | — | — |
| 毛利率 | — | 77.6% |
| 营业利润率 | 50.6% | -9.0% |
| 净利率 | — | — |
| 营收同比 | 143.7% | 12.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | $0.32 | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRSPT
| Q4 25 | $168.4M | $120.9M | ||
| Q3 25 | $87.3M | $115.6M | ||
| Q2 25 | $82.4M | $111.8M | ||
| Q1 25 | $65.0M | $109.3M | ||
| Q4 24 | $69.1M | $107.1M | ||
| Q3 24 | $51.6M | $102.6M | ||
| Q2 24 | $73.8M | $99.4M | ||
| Q1 24 | $137.7M | $96.8M |
净利润ESPRSPT
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-9.4M | ||
| Q2 25 | $-12.7M | $-12.0M | ||
| Q1 25 | $-40.5M | $-11.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-17.1M | ||
| Q2 24 | $-61.9M | $-16.9M | ||
| Q1 24 | $61.0M | $-13.6M |
毛利率ESPRSPT
| Q4 25 | — | 77.6% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 77.7% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.1% | ||
| Q3 24 | — | 77.4% | ||
| Q2 24 | — | 77.5% | ||
| Q1 24 | — | 76.8% |
营业利润率ESPRSPT
| Q4 25 | 50.6% | -9.0% | ||
| Q3 25 | -11.4% | -7.9% | ||
| Q2 25 | 8.6% | -11.0% | ||
| Q1 25 | -34.0% | -10.2% | ||
| Q4 24 | -6.4% | -12.8% | ||
| Q3 24 | -31.0% | -16.4% | ||
| Q2 24 | 3.5% | -16.6% | ||
| Q1 24 | 52.5% | -13.7% |
净利率ESPRSPT
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -8.1% | ||
| Q2 25 | -15.4% | -10.7% | ||
| Q1 25 | -62.2% | -10.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -16.6% | ||
| Q2 24 | -83.9% | -17.0% | ||
| Q1 24 | 44.3% | -14.0% |
每股收益（稀释后）ESPRSPT
| Q4 25 | $0.32 | $-0.18 | ||
| Q3 25 | $-0.16 | $-0.16 | ||
| Q2 25 | $-0.06 | $-0.21 | ||
| Q1 25 | $-0.21 | $-0.19 | ||
| Q4 24 | $-0.14 | $-0.25 | ||
| Q3 24 | $-0.15 | $-0.30 | ||
| Q2 24 | $-0.33 | $-0.30 | ||
| Q1 24 | $0.34 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $95.3M |
| 总债务越低越好 | — | $40.0M |
| 股东权益账面价值 | $-302.0M | $203.4M |
| 总资产 | $465.9M | $523.1M |
| 负债/权益比越低杠杆越低 | — | 0.20× |
8季度趋势，按日历期对齐
现金及短期投资ESPRSPT
| Q4 25 | $167.9M | $95.3M | ||
| Q3 25 | $92.4M | $90.6M | ||
| Q2 25 | $86.1M | $101.5M | ||
| Q1 25 | $114.6M | $100.9M | ||
| Q4 24 | $144.8M | $86.4M | ||
| Q3 24 | $144.7M | $82.9M | ||
| Q2 24 | $189.3M | $80.9M | ||
| Q1 24 | $226.6M | $69.2M |
总债务ESPRSPT
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $25.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ESPRSPT
| Q4 25 | $-302.0M | $203.4M | ||
| Q3 25 | $-451.4M | $194.1M | ||
| Q2 25 | $-433.5M | $184.6M | ||
| Q1 25 | $-426.2M | $175.3M | ||
| Q4 24 | $-388.7M | $166.6M | ||
| Q3 24 | $-370.2M | $158.1M | ||
| Q2 24 | $-344.2M | $152.1M | ||
| Q1 24 | $-294.3M | $147.3M |
总资产ESPRSPT
| Q4 25 | $465.9M | $523.1M | ||
| Q3 25 | $364.0M | $481.4M | ||
| Q2 25 | $347.1M | $422.9M | ||
| Q1 25 | $324.0M | $424.7M | ||
| Q4 24 | $343.8M | $428.3M | ||
| Q3 24 | $314.1M | $388.8M | ||
| Q2 24 | $352.3M | $393.6M | ||
| Q1 24 | $373.1M | $389.9M |
负债/权益比ESPRSPT
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | — | $9.9M |
| 自由现金流率自由现金流/营收 | — | 8.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $39.3M |
8季度趋势，按日历期对齐
经营现金流ESPRSPT
| Q4 25 | $45.2M | $10.9M | ||
| Q3 25 | $-4.3M | $9.3M | ||
| Q2 25 | $-31.4M | $5.1M | ||
| Q1 25 | $-22.6M | $18.1M | ||
| Q4 24 | $-35.0M | $4.1M | ||
| Q3 24 | $-35.3M | $9.0M | ||
| Q2 24 | $-7.2M | $2.1M | ||
| Q1 24 | $53.8M | $11.2M |
自由现金流ESPRSPT
| Q4 25 | — | $9.9M | ||
| Q3 25 | — | $8.5M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $16.7M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $-35.5M | $8.5M | ||
| Q2 24 | $-7.3M | $1.6M | ||
| Q1 24 | $53.8M | $10.1M |
自由现金流率ESPRSPT
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -68.7% | 8.3% | ||
| Q2 24 | -9.9% | 1.6% | ||
| Q1 24 | 39.0% | 10.4% |
资本支出强度ESPRSPT
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 1.1% |
现金转化率ESPRSPT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SPT
暂无分部数据
